SGK1 and metabolic syndrome: Interestingly, chronic dexamethasone suppresses SGK1 in the hypothalamic arcuate nucleus, thereby increasing obesity and metabolic syndrome [75], indicating a significant GR effect in the hypothalamus that may be modulated by variations in pineal and local melatonin.